Monday deadline: nrx pharmaceuticals, inc. investors with significant losses have opportunity to lead class action lawsuit - nrxp; nrxpw

San diego , march 17, 2022 /prnewswire/ -- robbins geller rudman & dowd llp announces that purchasers or acquirers of nrx pharmaceuticals, inc. (nasdaq: nrxp; nrxpw) securities between june 1, 2021 and november 4, 2021, both dates inclusive (the "class period") have until this upcoming monday, march 21, 2022 to seek appointment as lead plaintiff in dal bosco v. nrx pharmaceuticals, inc., no.
NRXP Ratings Summary
NRXP Quant Ranking